✦ LIBER ✦

P.3.c.034 Polypharmacy in schizophrenia treatment

✍ Scribed by C. Tsopelas; P. Ntounas; A. Konsta; E. Rizos; D. Pappas; P. Chatzimanolis; M. Dimitraka; C. Touloumis; A. Douzenis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.b.034 Insight, treatment outcomes an

✍ Agid, O.; Siu, C.O.; Harvey, P.D.; Zipursky, R.B.; Remington, G. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P.3.c.034 Italian Society of Psychiatry

✍ E. Aguglia; M. Di Giannantonio; C. Altamura; L. Ferrannini; S. Galderisi; C. Men 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Antipsychotic polypharmacy in the treatm

✍ C.U. Cornell; J.M. Kane; D. O'Shea; K. Razi; A.K. Malhotra 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 124 KB

P.3.c.034 Eufest: the moderating impact

✍ W. Fleischhacker; R. Kahn; O. Karayal; C. Siu; E. Pappadopulos 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 187 KB

P.3.c.042 Antipsychotic polypharmacy and

✍ D. Kontis; S. Kleisas; E. Theochari; S. Kalogerakou; A. Andreopoulou; S. Vassilo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Critical review of antipsychotic polypha

✍ Fleischhacker, W. Wolfgang; Uchida, Hiroyuki 📂 Article 📅 2012 🏛 Cambridge University Press 🌐 English ⚖ 120 KB